Dr. Stephen Gladdin, M.D

NPI: 1386692671
Total Payments
$35,700
2024 Payments
$25.00
Companies
6
Transactions
85
Medicare Patients
26
Medicare Billing
$4,072

Payment Breakdown by Category

Other$24,950 (69.9%)
Consulting$6,174 (17.3%)
Travel$2,610 (7.3%)
Food & Beverage$1,941 (5.4%)
Education$25.60 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,950 16 69.9%
Consulting Fee $6,174 8 17.3%
Travel and Lodging $2,610 31 7.3%
Food and Beverage $1,941 27 5.4%
Education $25.60 3 0.1%

Top Paying Companies

Company Total Records Latest Year
AMAG Pharmaceuticals, Inc. $27,630 65 $0 (2018)
GE HEALTHCARE $5,513 7 $0 (2023)
Covidien LP $1,457 8 $0 (2017)
Northgate Technologies, Inc. $800.00 1 $0 (2021)
AbbVie Inc. $276.14 3 $0 (2020)
Bayer Healthcare Pharmaceuticals Inc. $25.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $25.00 1 Bayer Healthcare Pharmaceuticals Inc. ($25.00)
2023 $625.00 1 GE HEALTHCARE ($625.00)
2022 $2,262 2 GE HealthCare ($2,262)
2021 $800.00 1 Northgate Technologies, Inc. ($800.00)
2020 $1,580 2 GE HEALTHCARE ($1,560)
2019 $709.64 2 GE HEALTHCARE ($574.00)
2018 $15,352 41 AMAG Pharmaceuticals, Inc. ($15,232)
2017 $14,347 35 AMAG Pharmaceuticals, Inc. ($12,398)

All Payment Transactions

85 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
06/07/2024 Bayer Healthcare Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $25.00 General
09/01/2023 GE HEALTHCARE Vscan (Device) Consulting Fee Cash or cash equivalent $625.00 General
Category: Ultrasound
06/03/2022 GE HealthCare Versana (Device) Consulting Fee Cash or cash equivalent $1,012.00 General
Category: Ultrasound
04/06/2022 GE HealthCare Consulting Fee Cash or cash equivalent $1,250.00 General
06/28/2021 Northgate Technologies, Inc. Consulting Fee Cash or cash equivalent $800.00 General
08/25/2020 AbbVie Inc. ORIAHNN (Drug) Food and Beverage In-kind items and services $20.14 General
Category: WOMENS HEALTH
08/05/2020 GE HEALTHCARE Consulting Fee Cash or cash equivalent $1,560.00 General
Category: ULTRASOUND
06/20/2019 GE HEALTHCARE Consulting Fee Cash or cash equivalent $574.00 General
Category: DETECTION & GUIDANCE SOLUTIONS
01/22/2019 AbbVie, Inc. Orilissa (Drug) Food and Beverage In-kind items and services $135.64 General
Category: Endocrinology
09/11/2018 AbbVie, Inc. Lupron (Drug) Food and Beverage In-kind items and services $120.36 General
Category: Endocrinology
08/22/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $38.15 General
Category: TREATMENT OF DYSPAREUNIA
08/21/2018 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Education In-kind items and services $5.34 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
08/15/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,600.00 General
Category: TREATMENT OF DYSPAREUNIA
08/08/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,600.00 General
Category: TREATMENT OF DYSPAREUNIA
08/08/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $27.80 General
Category: TREATMENT OF DYSPAREUNIA
08/08/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $4.00 General
Category: TREATMENT OF DYSPAREUNIA
08/07/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Food and Beverage In-kind items and services $120.00 General
Category: TREATMENT OF DYSPAREUNIA
07/31/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Food and Beverage In-kind items and services $92.32 General
Category: TREATMENT OF DYSPAREUNIA
07/31/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging In-kind items and services $28.51 General
Category: TREATMENT OF DYSPAREUNIA
07/30/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,600.00 General
Category: TREATMENT OF DYSPAREUNIA
07/30/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $21.80 General
Category: TREATMENT OF DYSPAREUNIA
07/25/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Food and Beverage In-kind items and services $104.95 General
Category: TREATMENT OF DYSPAREUNIA
06/25/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $34.11 General
Category: TREATMENT OF DYSPAREUNIA
06/25/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Travel and Lodging Cash or cash equivalent $4.50 General
Category: TREATMENT OF DYSPAREUNIA
06/06/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,600.00 General
Category: TREATMENT OF DYSPAREUNIA

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 1 14 24 $4,800 $2,242
2020 1 12 22 $4,400 $1,831
Total Patients
26
Total Services
46
Medicare Billing
$4,072
Procedure Codes
2

All Medicare Procedures & Services

2 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 14 24 $4,800 $2,242 46.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 12 22 $4,400 $1,831 41.6%

About Dr. Stephen Gladdin, M.D

Dr. Stephen Gladdin, M.D is a Obstetrics & Gynecology healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386692671.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Gladdin, M.D has received a total of $35,700 in payments from pharmaceutical and medical device companies, with $25.00 received in 2024. These payments were reported across 85 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,950).

As a Medicare-enrolled provider, Gladdin has provided services to 26 Medicare beneficiaries, totaling 46 services with total Medicare billing of $4,072. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Elgin, IL
  • Active Since 05/05/2006
  • Last Updated 12/14/2021
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1386692671

Products in Payments

  • INTRAROSA (Drug) $27,604
  • Versana (Device) $1,012
  • V-Loc (Device) $828.71
  • Vscan (Device) $625.00
  • LigaSure (Device) $502.46
  • LOTUS-FT3 (Device) $492.00
  • Orilissa (Drug) $135.64
  • LigaSure Advance (Device) $125.43
  • Lupron (Drug) $120.36
  • ORIAHNN (Drug) $20.14
  • MAKENA (Drug) $10.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Elgin